Mendelian randomization of serum urate and parkinson disease progression. - Wikidata - wikimedia - TriplyDB

Mendelian randomization of serum urate and parkinson disease progression.

Mendelian randomization of serum urate and parkinson disease progression.

http://www.wikidata.org/entity/Q34576895

about

The prediagnostic phase of Parkinson's disease Serum uric acid levels and multiple health outcomes: umbrella review of evidence from observational studies, randomised controlled trials, and Mendelian randomisation studies Contra-Directional Expression of Serum Homocysteine and Uric Acid as Important Biomarkers of Multiple System Atrophy Severity: A Cross-Sectional Study.Prospective study of plasma urate and risk of Parkinson disease in men and women.Mendelian Randomization - the Key to Understanding Aspects of Parkinson's Disease Causation?Genetically Low Vitamin D Levels, Bone Mineral Density, and Bone Metabolism Markers: a Mendelian Randomisation Study.The Role of Uric Acid and Methyl Derivatives in the Prevention of Age-Related Neurodegenerative Disorders.Urate Levels Predict Survival in ALS: Analysis of the Expanded PRO-ACT Database.Nature as a Trialist?: Deconstructing the Analogy Between Mendelian Randomization and Randomized Trials.Advances in Biomarker Research in Parkinson's Disease.No clear support for a role for vitamin D in Parkinson's disease: A Mendelian randomization study.Advances in understanding genomic markers and pharmacogenetics of Parkinson's disease.Urate as a Marker of Risk and Progression of Neurodegenerative Disease.Targeting urate to reduce oxidative stress in Parkinson disease.Low serum uric acid levels in progressive supranuclear palsy.No causal effect of serum urate on bone-related outcomes among a population of postmenopausal women and elderly men of Chinese Han ethnicity--a Mendelian randomization study.Immunohistochemical and in situ hybridization study of urate transporters GLUT9/URATv1, ABCG2, and URAT1 in the murine brain.The significance of uric acid in the diagnosis and treatment of Parkinson disease: An updated systemic review.The Changing Landscape of Parkinson Epidemiologic Research.Genome-wide variant by serum urate interaction in Parkinson's disease.Glut9-mediated Urate Uptake Is Responsible for Its Protective Effects on Dopaminergic Neurons in Parkinson's Disease Models.Potential mechanisms for low uric acid in Parkinson disease.Genome-wide association analysis identifies multiple loci associated with kidney disease-related traits in Korean populations.ALSUntangled No. 37: Inosine*

P2860

Q26768732-399BEE11-6C92-4C99-82F9-8CB8D19AF932 Q33770852-822401F1-B5FA-4F76-8919-2D5355A76FAF Q35820242-F649B0CD-DA2F-4ACC-98FD-B610C57028B6 Q36580376-CD56B1C9-08BD-4DDB-B311-7A32ECE10C50 Q37090660-6F1AA93E-80D2-4DDD-9FB3-796CF53EAEEF Q37254219-F257B217-471A-436B-9C7C-B31C975DFADA Q38522643-9727D36D-9EE7-497A-A998-2899560C5CF8 Q38600633-0D76ADE6-7B1F-4961-9CD6-2D6680CAF99A Q38673762-C6F90B61-D02B-49D3-AF09-81D7A90A3820 Q38681599-B7B3DD17-6BB7-479A-9C5A-FBF2770CBF8A Q38736768-5BA6BDF3-0A98-45B8-B13B-F4F8BC82E04A Q38748158-648747E9-EB4C-40FD-8A53-FF39245D839E Q39044143-D2024E2C-4C98-423A-B040-BD3539EE8EDA Q39379023-BF287CC5-579B-4CBD-96F8-40E620AA741B Q40190481-B3D37A21-C28A-4BA4-8FCB-87FB5FF8FA05 Q40296281-37C315FD-5754-41AB-AB8C-A4195001C6E5 Q42247910-921FB441-D170-4A7E-A770-80E173BE5632 Q47597895-A434DDF0-E264-454C-80F4-C410B91251C0 Q47662113-F2E5F5F0-DD3B-4B6A-A3BA-8712AADD744A Q48075588-A4417C82-CC63-40CD-B9D5-9F850BBAFA54 Q49698299-1AC0EC59-9231-42DA-B5A5-E0BB75C3E415 Q53328368-33C0EB2A-79AB-4D1B-B69B-D906A943B8E4 Q54943914-B95A3ACE-7DF2-413F-BCDE-ED69B56EE69D Q57464278-9091DCCE-A213-4DBE-9C16-0C31D0D5263C

P2860

Mendelian randomization of serum urate and parkinson disease progression.

http://www.wikidata.org/entity/Q34576895

description

2014 nî lūn-bûn

@nan

2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Mendelian randomization of serum urate and parkinson disease progression.

@ast

Mendelian randomization of serum urate and parkinson disease progression.

@en

Mendelian randomization of serum urate and parkinson disease progression.

@nl

type

label

Mendelian randomization of serum urate and parkinson disease progression.

@ast

Mendelian randomization of serum urate and parkinson disease progression.

@en

Mendelian randomization of serum urate and parkinson disease progression.

@nl

prefLabel

Mendelian randomization of serum urate and parkinson disease progression.

@ast

Mendelian randomization of serum urate and parkinson disease progression.

@en

Mendelian randomization of serum urate and parkinson disease progression.

@nl

P1433

Q34576895-42651585-C26A-47E7-A3CF-127EE3E1AEB2

P1476

Q34576895-D323D07E-3971-4171-B12C-E1C79A3D97E1

P2093

Q34576895-2A4CDF40-1982-4830-82BB-00E3819FFB76

Q34576895-547F2279-FF87-4F8C-B666-449AA50F0B50

Q34576895-8FDF2564-C421-4DEA-AA1B-389A3BE816FB

Q34576895-CE39BB0D-A66D-4AD2-A42F-7ED45B81BD24

Q34576895-D299858E-7310-4115-B49B-17A7F7DC4C75

Q34576895-D5CAE647-7599-43F2-BBA3-BE997C78E5CD

P2860

Q34576895-011019C8-6D8B-4279-B7EA-6D61D4D6168E

Q34576895-054E3CB9-A90B-44EF-8584-07C1AEAB2853

Q34576895-08D8C841-BB5D-4C6F-A6A4-4A74F5CBC0BC

Q34576895-0D5B49B6-7385-4856-8AAB-F92816EB1F14

Q34576895-1431F83C-8B7D-4172-B501-224D9A125331

Q34576895-1BE268F8-C481-4214-BDA2-5DE59DCC1418

Q34576895-1D18DCC9-4B80-472F-94FE-25AC444CA9F6

Q34576895-22EF2FA2-4DE1-4332-999F-529FA7E18BC5

Q34576895-2E1D978D-8069-460D-BD0A-C4C53094020D

Q34576895-3491D66D-543D-4016-BCFC-E81BF1C2A6CF

P304

Q34576895-81571AC4-55B0-455E-8027-17ADFCD4F0CC

P31

Q34576895-1CDC6331-D272-4183-9B9D-451F83F4045D

P356

Q34576895-67B356D0-9F70-4FB6-A15E-0D14E4374066

P433

Q34576895-E5F0A7D1-8A7E-4B93-91D9-D5CA7FDF5B5F

P478

Q34576895-EB65A2F3-18C0-49DF-B663-87D82D5F112C

P50

Q34576895-37829F12-D735-4642-B994-B69DF4A218D1

Q34576895-515AD8CE-48AD-4628-BF0C-1EE185B1EF94

Q34576895-8F49DAD2-51BE-4F21-88D9-A98EFCD22C33

Q34576895-A099E225-2BDB-4036-9182-C2E914DD8A4E

P577

Q34576895-BDECA853-9EB6-4712-9EBB-B552729C03BA

P698

Q34576895-0D673AE5-103C-40D0-A37F-8D581679617D

P921

Q34576895-F9B56D41-C981-4BFA-862D-379CB60DE635

P932

Q34576895-E8068569-8251-46FA-BB6E-60A55BD45533

P356

P1433

Annals of Neurology

P1476

Mendelian randomization of serum urate and parkinson disease progression.

@en

P2093

David Oakes

http://www.w3.org/2001/XMLSchema#string

Ira Shoulson

http://www.w3.org/2001/XMLSchema#string

Kelly Claire Simon

http://www.w3.org/2001/XMLSchema#string

Parkinson Study Group

http://www.w3.org/2001/XMLSchema#string

Shirley Eberly

http://www.w3.org/2001/XMLSchema#string

Xiang Gao

http://www.w3.org/2001/XMLSchema#string

P2860

Meta-analysis of 28,141 individuals identifies common variants within five new loci that influence uric acid concentrations

Cloning and expression analysis of a novel member of the facilitative glucose transporter family, SLC2A9 (GLUT9)

Association of three genetic loci with uric acid concentration and risk of gout: a genome-wide association study

Imputation of sequence variants for identification of genetic risks for Parkinson's disease: a meta-analysis of genome-wide association studies

Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: a hypothesis

Genome-wide association study identifies genes for biomarkers of cardiovascular disease: serum urate and dyslipidemia

The International HapMap Project

Haploview: analysis and visualization of LD and haplotype maps

SLC2A9 is a newly identified urate transporter influencing serum urate concentration, urate excretion and gout

SLC2A9 is a high-capacity urate transporter in humans

P304

862-868

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/ANA.24281

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

76

http://www.w3.org/2001/XMLSchema#string

P50

Caroline M Tanner

Michael A Schwarzschild

Alberto Ascherio

P577

2014-10-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25257975

http://www.w3.org/2001/XMLSchema#string

P921

Parkinson's disease

P932

4245314

http://www.w3.org/2001/XMLSchema#string